{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T02:56:40Z","timestamp":1790823400844,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Specific Research Project of Guangxi for Research Bases and Talents","award":["GuiKe AD22035057"],"award-info":[{"award-number":["GuiKe AD22035057"]}]},{"name":"the Specific Research Project of Guangxi for Research Bases and Talents","award":["GuiKe AD22035057"],"award-info":[{"award-number":["GuiKe AD22035057"]}]},{"name":"the Specific Research Project of Guangxi for Research Bases and Talents","award":["GuiKe AD22035057"],"award-info":[{"award-number":["GuiKe AD22035057"]}]},{"name":"the Specific Research Project of Guangxi for Research Bases and Talents","award":["GuiKe AD22035057"],"award-info":[{"award-number":["GuiKe AD22035057"]}]},{"name":"the Specific Research Project of Guangxi for Research Bases and Talents","award":["GuiKe AD22035057"],"award-info":[{"award-number":["GuiKe AD22035057"]}]},{"name":"the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","award":["GKE-ZZ202217"],"award-info":[{"award-number":["GKE-ZZ202217"]}]},{"name":"the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","award":["GKE-ZZ202217"],"award-info":[{"award-number":["GKE-ZZ202217"]}]},{"name":"the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","award":["GKE-ZZ202217"],"award-info":[{"award-number":["GKE-ZZ202217"]}]},{"name":"the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","award":["GKE-ZZ202217"],"award-info":[{"award-number":["GKE-ZZ202217"]}]},{"name":"the Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education","award":["GKE-ZZ202217"],"award-info":[{"award-number":["GKE-ZZ202217"]}]},{"name":"Guangxi TCM appropriate technology development and promotion project","award":["GZSY23-66"],"award-info":[{"award-number":["GZSY23-66"]}]},{"name":"Guangxi TCM appropriate technology development and promotion project","award":["GZSY23-66"],"award-info":[{"award-number":["GZSY23-66"]}]},{"name":"Guangxi TCM appropriate technology development and promotion project","award":["GZSY23-66"],"award-info":[{"award-number":["GZSY23-66"]}]},{"name":"Guangxi TCM appropriate technology development and promotion project","award":["GZSY23-66"],"award-info":[{"award-number":["GZSY23-66"]}]},{"name":"Guangxi TCM appropriate technology development and promotion project","award":["GZSY23-66"],"award-info":[{"award-number":["GZSY23-66"]}]},{"name":"Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital","award":["NO.2023-7"],"award-info":[{"award-number":["NO.2023-7"]}]},{"name":"Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital","award":["NO.2023-7"],"award-info":[{"award-number":["NO.2023-7"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-12929-9","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:04:13Z","timestamp":1727445853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Preoperative monocyte-to-lymphocyte ratio as a prognosis predictor after curative hepatectomy for intrahepatic cholangiocarcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Bin-Feng","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Nan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9830-0197","authenticated-orcid":false,"given":"Rong-yun","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"2","key":"12929_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","volume":"73","author":"D Moris","year":"2023","unstructured":"Moris D, Palta M, Kim C, et al. Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians. CA Cancer J Clin. 2023;73(2):198\u2013222.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"12929_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","volume":"21","author":"SK Saha","year":"2016","unstructured":"Saha SK, Zhu AX, Fuchs CS, et al. Forty-year trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the rise. Oncologist. 2016;21(5):594\u20139.","journal-title":"Oncologist"},{"issue":"1","key":"12929_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000530700","volume":"13","author":"L Ye","year":"2024","unstructured":"Ye L, Schneider JS, Ben Khaled N, et al. Combined Hepatocellular-Cholangiocarcinoma: Biology, diagnosis, and management. Liver Cancer. 2024;13(1):6\u201328.","journal-title":"Liver Cancer"},{"issue":"1","key":"12929_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14737140.2022.1999809","volume":"22","author":"DB Hewitt","year":"2022","unstructured":"Hewitt DB, Brown ZJ, Pawlik TM. Surgical management of intrahepatic cholangiocarcinoma. Expert Rev Anticancer Ther. 2022;22(1):27\u201338.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"6","key":"12929_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2174\/1568009621666210204152028","volume":"21","author":"M Nguyen","year":"2021","unstructured":"Nguyen M, Toan NL, Bozko M, et al. Cholangiocarcinoma therapeutics: an update. Curr Cancer Drug Targets. 2021;21(6):457\u201375.","journal-title":"Curr Cancer Drug Targets"},{"issue":"9","key":"12929_CR6","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin J, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol. 2020;17(9):557\u201388.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"12929_CR7","doi-asserted-by":"publisher","first-page":"193","DOI":"10.2174\/187153032102210105105653","volume":"21","author":"SU Venakteshaiah","year":"2021","unstructured":"Venakteshaiah SU, Kumar KH. Inflammation and Cancer. Endocr Metab Immune Disord Drug Targets. 2021;21(2):193\u20134.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"11","key":"12929_CR8","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.trecan.2022.07.002","volume":"8","author":"D Denk","year":"2022","unstructured":"Denk D, Greten FR. Inflammation: the incubator of the tumor microenvironment. Trends Cancer. 2022;8(11):901\u201314.","journal-title":"Trends Cancer"},{"key":"12929_CR9","doi-asserted-by":"publisher","first-page":"153303382199528","DOI":"10.1177\/1533033821995282","volume":"20","author":"Q Lv","year":"2021","unstructured":"Lv Q, Xia Q, Li A, et al. The potential role of IL1RAP on Tumor Microenvironment-related inflammatory factors in stomach adenocarcinoma. Technol Cancer Res Treat. 2021;20:1533033821995282.","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"12929_CR10","doi-asserted-by":"publisher","first-page":"5281","DOI":"10.18632\/oncotarget.14136","volume":"8","author":"F Feng","year":"2017","unstructured":"Feng F, Sun L, Zheng G, et al. Low lymphocyte-to-white blood cell ratio and high monocyte-to-white blood cell ratio predict poor prognosis in gastric cancer. Oncotarget. 2017;8(3):5281\u201391.","journal-title":"Oncotarget"},{"issue":"2","key":"12929_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hed.27246","volume":"45","author":"X Hu","year":"2023","unstructured":"Hu X, Tian T, Zhang X, et al. Neutrophil-to-lymphocyte and hypopharyngeal cancer prognosis: System review and meta-analysis. Head Neck. 2023;45(2):492\u2013502.","journal-title":"Head Neck"},{"issue":"4","key":"12929_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1177\/03936155221118098","volume":"37","author":"Z Gong","year":"2022","unstructured":"Gong Z, Xin R, Li L, et al. Platelet-to-lymphocyte ratio associated with the clinicopathological features and prognostic value of breast cancer: a meta-analysis. Int J Biol Markers. 2022;37(4):339\u201348.","journal-title":"Int J Biol Markers"},{"issue":"1","key":"12929_CR13","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/16078454.2022.2055857","volume":"27","author":"S Zhao","year":"2022","unstructured":"Zhao S, Pan H, Guo Q, et al. Platelet to white blood cell ratio was an independent prognostic predictor in acute myeloid leukemia. Hematology. 2022;27(1):426\u201330.","journal-title":"Hematology"},{"issue":"34","key":"12929_CR14","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.3748\/wjg.v23.i34.6261","volume":"23","author":"JH Chen","year":"2017","unstructured":"Chen JH, Zhai ET, Yuan YJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol. 2017;23(34):6261\u201372.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"12929_CR15","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.3892\/ol.2020.11655","volume":"20","author":"L Wang","year":"2020","unstructured":"Wang L, Si H, Wang J, et al. Blood cell parameters as prognostic predictors of disease development for patients with advanced non-small cell lung cancer. Oncol Lett. 2020;20(2):1101\u201310.","journal-title":"Oncol Lett"},{"issue":"1","key":"12929_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/jso.25290","volume":"119","author":"F Cananzi","year":"2019","unstructured":"Cananzi F, Minerva EM, Sam\u00e0 L, et al. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors. J Surg Oncol. 2019;119(1):12\u201320.","journal-title":"J Surg Oncol"},{"issue":"5","key":"12929_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S1470-2045(20)30109-1","volume":"21","author":"GK Abou-Alfa","year":"2020","unstructured":"Abou-Alfa GK, Sahai V, Hollebecque A, et al. Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2020;21(5):671\u201384.","journal-title":"Lancet Oncol"},{"issue":"10360","key":"12929_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","volume":"400","author":"A Vogel","year":"2022","unstructured":"Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345\u201362.","journal-title":"Lancet"},{"issue":"7","key":"12929_CR19","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1089\/lap.2019.0615","volume":"30","author":"N DelPiccolo","year":"2020","unstructured":"DelPiccolo N, Onkendi E, Nguyen J, et al. Outcomes of minimally invasive Versus Open Major hepatic resection. J Laparoendosc Adv Surg Tech A. 2020;30(7):790\u20136.","journal-title":"J Laparoendosc Adv Surg Tech A"},{"key":"12929_CR20","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2147\/CMAR.S186114","volume":"11","author":"RY Mai","year":"2019","unstructured":"Mai RY, Ye JZ, Long ZR, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res. 2019;11:1401\u201314.","journal-title":"Cancer Manag Res"},{"issue":"5","key":"12929_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, D\u2019Angelica MI, Abbott DE, et al. Hepatobiliary cancers, Version 2.2021, NCCN Clinical Practice guidelines in Oncology. J Natl Compr Canc Netw. 2021;19(5):541\u201365.","journal-title":"J Natl Compr Canc Netw"},{"key":"12929_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.2147\/JIR.S441623","volume":"17","author":"RY Mai","year":"2024","unstructured":"Mai RY, Lu TL, Lu RJ, et al. C-Reactive protein-albumin ratio (CAR): a more promising inflammation-based prognostic marker for patients undergoing curative hepatectomy for Hepatocellular Carcinoma. J Inflamm Res. 2024;17:919\u201331.","journal-title":"J Inflamm Res"},{"issue":"23","key":"12929_CR23","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1002\/sim.9848","volume":"42","author":"R Dey","year":"2023","unstructured":"Dey R, Hanley JA, Saha-Chaudhuri P. Inference for covariate-adjusted time-dependent prognostic accuracy measures. Stat Med. 2023;42(23):4082\u2013110.","journal-title":"Stat Med"},{"issue":"2","key":"12929_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s11255-019-02307-x","volume":"52","author":"W Zhuang","year":"2020","unstructured":"Zhuang W, Chen J, Li Y, et al. Valuation of lymph node dissection in localized high-risk renal cell cancer using X-tile software. Int Urol Nephrol. 2020;52(2):253\u201362.","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"12929_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/codi.16824","volume":"26","author":"MS Johnstone","year":"2024","unstructured":"Johnstone MS, McSorley ST, McMillan DC, et al. The relationship between systemic inflammatory response, screen detection and outcome in colorectal cancer. Colorectal Dis. 2024;26(1):81\u201394.","journal-title":"Colorectal Dis"},{"issue":"11","key":"12929_CR26","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, et al. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21(11):799\u2013820.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"12929_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11605-018-04086-9","volume":"24","author":"D Peng","year":"2020","unstructured":"Peng D, Lu J, Hu H, et al. Lymphocyte to monocyte ratio predicts resectability and early recurrence of Bismuth-Corlette type IV Hilar Cholangiocarcinoma. J Gastrointest Surg. 2020;24(2):330\u201340.","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"12929_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","volume":"18","author":"MA Cupp","year":"2020","unstructured":"Cupp MA, Cariolou M, Tzoulaki I, et al. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18(1):360.","journal-title":"BMC Med"},{"issue":"8","key":"12929_CR29","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1245\/s10434-020-08350-8","volume":"27","author":"A Moro","year":"2020","unstructured":"Moro A, Mehta R, Sahara K, et al. The impact of preoperative CA19-9 and CEA on outcomes of patients with Intrahepatic Cholangiocarcinoma. Ann Surg Oncol. 2020;27(8):2888\u2013901.","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"12929_CR30","doi-asserted-by":"publisher","first-page":"e118","DOI":"10.1038\/ctg.2017.45","volume":"8","author":"BH Zheng","year":"2017","unstructured":"Zheng BH, Yang LX, Sun QM, et al. A New Preoperative Prognostic System combining CRP and CA19-9 for patients with Intrahepatic Cholangiocarcinoma. Clin Transl Gastroenterol. 2017;8(10):e118.","journal-title":"Clin Transl Gastroenterol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12929-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12929-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T14:05:32Z","timestamp":1727445932000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12929-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12929"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12929-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was supervised by the ethics committee of Guangxi Medical University Cancer Hospital, and written informed consent was not needed since this was a retrospective study by decision of the ethics committee of Guangxi Medical University Cancer Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1179"}}